ANGIODYNAMICS INC (ANGO) — insider trading
Health Care · NASDAQ
ANGIODYNAMICS INC (ANGO) has 76 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases and 1 open-market sale among the most recent 76 (latest 2026-07-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-30 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Open-market sale | 23,370 | $14.72 | $344.0K | Form 4 |
| 2026-07-22 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Option exercise / conversion (derivative) | 22,768 | — | $0 | Form 4 |
| 2026-07-22 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 2,330 | $13.82 | $32.2K | Form 4 |
| 2026-07-22 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Option exercise / conversion | 6,466 | — | $0 | Form 4 |
| 2026-07-22 | Clemmer James C | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 184,361 | — | $0 | Form 4 |
| 2026-07-22 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 26,728 | $13.82 | $369.4K | Form 4 |
| 2026-07-22 | Clemmer James C | Director, Officer (President and CEO) | Option exercise / conversion | 52,358 | — | $0 | Form 4 |
| 2026-07-22 | Trowbridge Stephen A | Officer (EVP and CFO) | Option exercise / conversion (derivative) | 57,381 | — | $0 | Form 4 |
| 2026-07-22 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 8,319 | $13.82 | $115.0K | Form 4 |
| 2026-07-22 | Trowbridge Stephen A | Officer (EVP and CFO) | Option exercise / conversion | 16,296 | — | $0 | Form 4 |
| 2026-07-22 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Option exercise / conversion (derivative) | 20,052 | — | $0 | Form 4 |
| 2026-07-22 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 1,671 | $13.82 | $23.1K | Form 4 |
| 2026-07-22 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Option exercise / conversion | 5,694 | — | $0 | Form 4 |
| 2026-07-22 | Piccinini Laura | Officer (SVP International) | Option exercise / conversion (derivative) | 28,336 | — | $0 | Form 4 |
| 2026-07-22 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 4,506 | $13.82 | $62.3K | Form 4 |
| 2026-07-22 | Piccinini Laura | Officer (SVP International) | Option exercise / conversion | 8,047 | — | $0 | Form 4 |
| 2026-07-20 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 359 | $13.71 | $4.9K | Form 4 |
| 2026-07-20 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 4,223 | $13.71 | $57.9K | Form 4 |
| 2026-07-20 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 251 | $13.71 | $3.4K | Form 4 |
| 2026-07-20 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 616 | $13.71 | $8.4K | Form 4 |
| 2026-07-20 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 717 | $13.71 | $9.8K | Form 4 |
| 2026-07-19 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 487 | $13.51 | $6.6K | Form 4 |
| 2026-07-19 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 11,764 | $13.51 | $158.9K | Form 4 |
| 2026-07-17 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 1,112 | $13.51 | $15.0K | Form 4 |
| 2026-07-17 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 10,649 | $13.51 | $143.9K | Form 4 |
| 2026-07-17 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 1,373 | $13.51 | $18.5K | Form 4 |
| 2026-07-17 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 3,074 | $13.51 | $41.5K | Form 4 |
| 2026-07-17 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 3,510 | $13.51 | $47.4K | Form 4 |
| 2026-07-16 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 2,367 | $14.14 | $33.5K | Form 4 |
| 2026-07-16 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 18,588 | $14.14 | $262.8K | Form 4 |
| 2026-07-16 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 2,153 | $14.14 | $30.4K | Form 4 |
| 2026-07-16 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 4,538 | $14.14 | $64.2K | Form 4 |
| 2026-07-16 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 7,840 | $14.14 | $110.9K | Form 4 |
| 2026-07-16 | Weiss Lawrence T | Officer (SVP, Chief Legal Officer) | Shares withheld for taxes / exercise cost | 2,267 | $14.14 | $32.1K | Form 4 |
| 2026-07-15 | Weiss Lawrence T | Officer (SVP, Chief Legal Officer) | Grant / award / vesting (derivative) | 21,288 | — | $0 | Form 4 |
| 2026-07-15 | Weiss Lawrence T | Officer (SVP, Chief Legal Officer) | Grant / award / vesting | 21,288 | — | $0 | Form 4 |
| 2026-07-15 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Grant / award / vesting (derivative) | 16,081 | — | $0 | Form 4 |
| 2026-07-15 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Grant / award / vesting | 16,081 | — | $0 | Form 4 |
| 2026-07-15 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Grant / award / vesting (derivative) | 17,966 | — | $0 | Form 4 |
| 2026-07-15 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Grant / award / vesting | 17,966 | — | $0 | Form 4 |
| 2026-07-15 | Piccinini Laura | Officer (SVP International) | Grant / award / vesting (derivative) | 19,860 | — | $0 | Form 4 |
| 2026-07-15 | Piccinini Laura | Officer (SVP International) | Grant / award / vesting | 19,860 | — | $0 | Form 4 |
| 2026-07-15 | Trowbridge Stephen A | Officer (EVP and CFO) | Grant / award / vesting (derivative) | 53,257 | — | $0 | Form 4 |
| 2026-07-15 | Trowbridge Stephen A | Officer (EVP and CFO) | Grant / award / vesting | 53,257 | — | $0 | Form 4 |
| 2026-07-15 | Tarnoff Michael E | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2026-07-15 | Auen Eileen O'Shea | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2026-07-15 | Burgess Lorinda | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2026-07-15 | DONNELLY HOWARD W | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2026-07-15 | JOHNSON WESLEY | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2026-07-15 | Licitra Karen A | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2026-07-15 | REED JAN STERN | Director | Grant / award / vesting | 11,887 | — | $0 | Form 4 |
| 2025-10-21 | Weiss Lawrence T | Officer (SVP, Chief Legal Officer) | Open-market purchase | 10,000 | $11.81 | $118.1K | Form 4 |
| 2025-10-13 | Trowbridge Stephen A | Officer (EVP and CFO) | Open-market purchase | 890 | $11.16 | $9.9K | Form 4 |
| 2025-10-09 | Clemmer James C | Director, Officer (President and CEO) | Open-market purchase | 10,000 | $11.15 | $111.5K | Form 4 |
| 2025-07-21 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 395 | $8.99 | $3.6K | Form 4 |
| 2025-07-21 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 277 | $8.99 | $2.5K | Form 4 |
| 2025-07-21 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 667 | $8.99 | $6.0K | Form 4 |
| 2025-07-20 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 359 | $8.69 | $3.1K | Form 4 |
| 2025-07-20 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 3,673 | $8.99 | $33.0K | Form 4 |
| 2025-07-20 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 2,982 | $8.69 | $25.9K | Form 4 |
| 2025-07-20 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 251 | $8.69 | $2.2K | Form 4 |
| 2025-07-20 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 616 | $8.69 | $5.4K | Form 4 |
| 2025-07-20 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 717 | $8.69 | $6.2K | Form 4 |
| 2025-07-19 | Campbell Chad Thomas | Officer (SVP/GM, Vascular Access) | Shares withheld for taxes / exercise cost | 1,025 | $8.69 | $8.9K | Form 4 |
| 2025-07-19 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 8,307 | $8.69 | $72.2K | Form 4 |
| 2025-07-19 | Clemmer James C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 344 | $8.69 | $3.0K | Form 4 |
| 2025-07-19 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Shares withheld for taxes / exercise cost | 735 | $8.69 | $6.4K | Form 4 |
| 2025-07-19 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 1,983 | $8.69 | $17.2K | Form 4 |
| 2025-07-19 | Trowbridge Stephen A | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 2,585 | $8.69 | $22.5K | Form 4 |
| 2025-07-17 | Piccinini Laura | Officer (SVP International) | Shares withheld for taxes / exercise cost | 3,074 | $8.74 | $26.9K | Form 4 |
| 2025-07-16 | Weiss Lawrence T | Officer (SVP, Chief Legal Officer) | Grant / award / vesting (derivative) | 30,900 | — | $0 | Form 4 |
| 2025-07-16 | Weiss Lawrence T | Officer (SVP, Chief Legal Officer) | Grant / award / vesting | 30,900 | — | $0 | Form 4 |
| 2025-07-16 | Clemmer James C | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 206,253 | — | $0 | Form 4 |
| 2025-07-16 | Clemmer James C | Director, Officer (President and CEO) | Grant / award / vesting | 206,253 | — | $0 | Form 4 |
| 2025-07-16 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Grant / award / vesting (derivative) | 29,349 | — | $0 | Form 4 |
| 2025-07-16 | Nighan Warren JR | Officer (SVP Quality and Regulatory) | Grant / award / vesting | 29,349 | — | $0 | Form 4 |
Ask the chat about ANGO's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ANGIODYNAMICS INC (ANGO).
Last updated 2026-07-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.